Clinical study of tumor angiogenesis and perfusion imaging using multi-slice spiral computed tomography for breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 1, 2013, Pages 429-433

  Xu, Na ^a   Lei, Zhen ^a   Li, Xiao Long ^b   Zhang, Jun ^c   Li, Chen ^a   Feng, Guo Quan ^a   Li, Di Nuo ^a   Liu, Jing Yi ^a   Wei, Qiang ^a   Bian, Ting Ting ^a   Zou, Tian Yu ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c The Hospital of Shanqiao Group of China Railway   (China)

Author keywords

Breast tumor; Matrix metalloproteinase 2; Multi slice spiral CT; Perfusion; Vascular endothelial growth factor

Indexed keywords

EID: 84877146474     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.1.429     Document Type: Article

References (17)

1. Ahluwalia AS, Tarnawski A (2012). Critical Role of Hypoxia Sensor - HIF-1 in VEGF Gene Activation. Implications for Angiogenesis and Tissue Injury Healing. Curr Med Chem, 19, 90-7.
2. Al-Raawi D, Abu-El-Zahab H, El-Shinawi M, Mohamed MM (2011). Membrane type-1 matrix metalloproteinase (MT1- MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer. Int J Clin Exp Med, 4, 265-75.
3. Ghasemi M, Emadian O, Naghshvar F, et al (2011). Immunohistochemical expression of vascular endothelial growth factor and its correlation with tumor grade in breast ductal carcinoma. Acta Med Iran, 49, 776-9.
4. Jain R (2011). Perfusion CT imaging of brain tumors: an overview. Am J Neuroradiol, 32, 1570-7.
5. Jezierska A, Motyl T (2009). Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit, 15, RA32-40.
6. Jobim FC, Schwartsmann G, Xavier NL, et al (2008). [Expression of MMP-9 and VEGF in breast cancer: correlation with other prognostic indicators]. Rev Bras Ginecol Obstet, 30, 287-93.
7. Konukoglu D, Turhan MS, Celik V, Turna H (2007). Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients. Indian J Med Res, 125, 747-51.
8. Lei Z, Ma H, Xu N, Xi H (2011). The evaluation of antiangiogenic treatment effects for implanted rabbit VX2 breast tumors using functional multi-slice spiral computed tomography (f-MSCT). Eur J Radiol, 78, 277-81.
9. Leiva-Salinas C, Provenzale JM, Wintermark M (2011). Responses to the 10 most frequently asked questions about perfusion CT. Am J Roentgenol, 196, 53-60.
10. Park CM, Goo JM, Lee HJ, et al (2009). FN13762 murine breast cancer: region-by-region correlation of first-pass perfusion CT indexes with histologic vascular parameters. Radiology, 251, 721-30.
11. Perrot-Applanat M, Di Benedetto M (2012). Autocrine functions of VEGF in breast tumor cells: Adhesion, survival, migration and invasion. Cell Adh Migr, 6, 547-53.
12. Sachdev JC, Jahanzeb M (2008). Evolution of bevacizumabbased therapy in the management of breast cancer. Clin Breast Cancer, 8, 402-10.
13. Shimizu M, Saitoh Y, Itoh H (1990). Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues. Hum Pathol, 21, 607-12.
14. Sledge GW, Jr. (2002). Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Semin Oncol, 29, 104-10.
15. So A, Lee TY (2011). Quantitative myocardial CT perfusion: a pictorial review and the current state of technology development. J Cardiovasc Comput Tomogr, 5, 467-81.
16. SB, Somiari RI, Heckman CM, et al (2006). Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer, 119, 1403-11.
17. Vinothini G, Aravindraja C, Chitrathara K, Nagini S (2011). Correlation of matrix metalloproteinases and their inhibitors with hypoxia and angiogenesis in premenopausal patients with adenocarcinoma of the breast. Clin Biochem, 44, 969-74.